Prix PW Medtech Group Limited (01358.HK)

PW Medtech Group Ltd. is an investment holding company, which engages in the manufacture and sale of infusion set products. The company is headquartered in Beijing, Beijing and currently employs 1,356 full-time employees. The company went IPO on 2013-11-08. The firm operates its businesses through three segments. Infusion Set Business segment is mainly engaged in the R&D, manufacturing and sales of advanced infusion set, intravenous cannula products, insulin needles. Blood Purification Business segment is mainly involved in the R&D, manufacturing and sales of hemodialysis and blood purification medical devices. Regenerative Medical Biomaterials Business segment is mainly involved in the R&D and manufacturing of animal-derived tissue regenerative medical biomaterials and human tissue repair alternative product. The firm mainly operates its businesses in the domestic market.